NK cell immunopotentiators-loaded nanoliposomes enhance ADCC effect for targeted therapy against HER2-positive breast cancer

Abstract Trastuzumab serves as a cornerstone of first-line therapy for HER2-positive (HER2+) breast cancer; however, a significant challenge arises due to the emergence of resistance within approximately one year of commencement of treatment, particularly in advanced cases with metastatic disease wh...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Ruoxin Du, Changqing Cao, Dong Fan, Guodong Li, Shuangpeng Pu, Xinyao Xu, Mengmeng Liu, Gege Shi, Yuxin Wu, Qiang Hao, Yuan Gao, Juliang Zhang, Huadong Zhao, Cun Zhang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2025-02-01
סדרה:	Cell Communication and Signaling
נושאים:	HER2+ breast cancer Trastuzumab resistance Natural killer cell Antibody-dependent cell-mediated cytotoxicity Nanoliposomes
גישה מקוונת:	https://doi.org/10.1186/s12964-024-02023-9
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!